Product Information
TRIPLE ANTIBIOTIC PLUS OINT is a generic product labeled by AmerisourceBergen, priced at $0.1261 per GM under NDC 24385014303. Its NADAC has been published 671 times since Nov 28, 2013.
TRIPLE ANTIBIOTIC PLUS OINT
Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochlorideStrength
500; 3.5; 10000; 10 [iU]/g; mg/g; [iU]/g; mg/g
Manufacturer
AmerisourceBergenNDC
24385014303
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Approval Type
OTC MONOGRAPH DRUG
FDA Application
M004On Market Since
3/31/2012
Pharmacological Classes
Price Statistics
The NADAC for TRIPLE ANTIBIOTIC PLUS OINT has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 4.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1261 per GM |
|---|---|
| All-time high | $0.1427 (Dec 13, 2023) |
| All-time low | $0.1173 (Feb 19, 2014) |
| 52-week high | $0.1293 |
| 52-week low | $0.1261 |
| Median price | $0.1310 |
| Average price | $0.1307 |
| Largest weekly change | -12.5% (Dec 20, 2023) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bacitracin zinc, Neomycin sulfate, Polymyxin B sulfate, and Pramoxine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aminoglycoside Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIPLE ANTIBIOTIC PLUS OINT?
The current National Average Drug Acquisition Cost (NADAC) for TRIPLE ANTIBIOTIC PLUS OINT, manufactured by AmerisourceBergen, is $0.1261 per GM (NDC 24385014303), effective Sep 30, 2026.
How has the price of TRIPLE ANTIBIOTIC PLUS OINT changed over time?
Over the history we have for it, the NADAC for TRIPLE ANTIBIOTIC PLUS OINT has risen 4.1%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRIPLE ANTIBIOTIC PLUS OINT?
Since Nov 28, 2013, the NADAC for TRIPLE ANTIBIOTIC PLUS OINT has ranged from a low of $0.1173 (Feb 19, 2014) to a high of $0.1427 (Dec 13, 2023), with a median of $0.1310 per GM.
Are there cheaper alternatives to TRIPLE ANTIBIOTIC PLUS OINT?
No other NADAC-published product currently shares the active ingredient and strength of TRIPLE ANTIBIOTIC PLUS OINT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRIPLE ANTIBIOTIC PLUS OINT?
TRIPLE ANTIBIOTIC PLUS OINT (NDC 24385014303) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.